Initial Evaluation and Management of Suprapubic Mass in Males
The initial evaluation of a male presenting with a suprapubic mass should include urinalysis, imaging with ultrasound, and consideration of cystoscopy as these masses should be managed as potentially malignant until proven otherwise. 1
Diagnostic Approach
Initial Assessment
- Obtain a complete medical history focusing on urinary symptoms, duration of the mass, and risk factors for urological conditions 1
- Perform physical examination including digital rectal examination to assess prostate characteristics and any palpable masses 1
- Conduct urinalysis to evaluate for infection, hematuria, or other abnormalities 1
Imaging Studies
- Perform transabdominal or transrectal ultrasound as the first-line imaging modality for evaluation of a suprapubic mass 1
- Ultrasound can effectively differentiate between cystic and solid masses, assess vascularity, and determine relationship to surrounding structures 1
- For solid masses, ultrasound with Doppler should be obtained to assess vascularity which may suggest malignancy 1
Laboratory Testing
- Measure serum tumor markers if testicular involvement is suspected, including alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH) 1
- Assess renal function if hydronephrosis is present or if surgical intervention is being considered 1
- Measure post-void residual volume to evaluate for urinary retention 1
Differential Diagnosis
Urological Causes
- Bladder distention due to urinary retention (most common cause of a suprapubic mass) 2
- Bladder cancer (particularly if hematuria is present) 1
- Prostatic enlargement (benign prostatic hyperplasia or prostate cancer) 1
- Urethral stricture with secondary bladder distention 2
Non-Urological Causes
- Abdominal wall tumors (primary or metastatic) 3, 4
- Ectopic or wandering spleen (rare) 5
- Retrovesical masses (seminal vesicle cysts, prostatic utricle cysts, sarcomas) 6
Management Algorithm
For Suspected Urinary Retention
- Perform bladder scan or straight catheterization to confirm and quantify retention 2
- If confirmed, proceed with immediate bladder decompression via urethral catheterization 2
- Consider alpha-blocker therapy (e.g., tamsulosin) prior to catheter removal to improve chances of successful voiding 2
- Evaluate for underlying cause (BPH, neurological conditions, medications, constipation) 2
For Suspected Malignancy
If solid mass is identified on ultrasound, consider:
For suspected testicular involvement:
For Suspected Infection
- Obtain urine culture 1
- Initiate empiric antibiotics based on clinical presentation 1
- Drain any abscess if identified 6
Special Considerations
- Long-term indwelling catheters (particularly suprapubic catheters) increase risk for squamous cell carcinoma at the catheter site 3, 4, 7
- Patients with spinal cord injury are at increased risk for bladder malignancy and require vigilant monitoring 4
- Retrovesical masses in men often require exploratory laparotomy and histopathological examination for definitive diagnosis 6
- Testicular microlithiasis without a solid mass does not require further evaluation unless other risk factors are present 1
Follow-up Recommendations
- For patients with urinary retention who successfully void after catheter removal, inform them about increased risk for recurrent retention 2
- For indeterminate masses with normal tumor markers, consider repeat imaging in 6-8 weeks 1
- For patients requiring long-term catheterization, regular follow-up is essential to assess for complications including infection, stone formation, and malignancy 2, 4